Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
06/2003
06/19/2003US20030114692 Method for the preparation of citalopram
06/19/2003US20030114690 Process for the preparation of aniline compounds
06/19/2003US20030114688 By heterogeneously catalyzed gas-phase oxidation of hydrocarbon having at least four carbon atoms by means of oxygen-containing gases; catalyst comprising vanadium, phosphorus and oxygen
06/19/2003US20030114679 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
06/19/2003US20030114635 Synthesis of anhydroglycitol esters of improved colour
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114456 Antiinflammatory agents, analgesics, antipyretics
06/19/2003US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/19/2003US20030114441 Heterocyclic anti-epileptogenic agents and methods of use thereof
06/19/2003US20030114435 Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient
06/19/2003US20030113362 Ascorbate molecules are covalently bound to amino acids
06/19/2003US20030110577 Novel p-aminophenols and colorants containing said compounds
06/19/2003CA2470111A1 Production of chirally pure .alpha.-amino acids and n-sulfonyl .alpha.-amino acids
06/19/2003CA2469730A1 Novel methods for treatment of cardiac arrhythmia, synthesis, and methods of use
06/19/2003CA2469709A1 Substituted hydrazones as inhibitors of cyclooxygenase-2
06/19/2003CA2469519A1 Deuterated substituted dihydrofuranones and medicaments containing these compounds
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1318991A1 Benzoic acid derivatives and uses thereof
06/18/2003EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1318974A2 Resorcinol derivatives
06/18/2003EP1318805A2 Pharmaceutical composition containing citalopram
06/18/2003EP1098874B1 Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
06/18/2003EP1080061B1 Method for producing mixtures of 1,4-butanediol, tetrahydrofuran and gamma-butyrolactone
06/18/2003EP0907631B1 Inorganic ion receptor-active compounds
06/18/2003CN1425018A Novel chromophores for polymeric thin films and optical waveguide and devices comprising the same
06/18/2003CN1424910A IL-8 receptor antagonists
06/18/2003CN1111527C Sesquilterpenic internal ester compound for antiulcer of alimentary tract
06/18/2003CN1111526C Process for preparing phthalides
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/17/2003US6579993 Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
06/17/2003US6579991 Preparation of phthalic anhydride by oxidation of o-xylene with hot air in a reactor, the hot reaction gas being passed through a heat exchanger for interaction with cooling medium
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/17/2003US6579879 For therapy of diabetic neuropathy, diabetic retinopathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic microangiopathy and diabetic macroangiopathy in mammals
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/17/2003CA2291133C Method for the preparation of citalopram
06/12/2003WO2003048147A2 PREPARATION OF CIS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES
06/12/2003WO2003048146A1 PREPARATION OF TRANS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES
06/12/2003WO2003048145A2 Method for preparing an aminobenzofuran compound
06/12/2003WO2003048144A2 Method for monosulphonylation of an aminobenzofuran compound
06/12/2003WO2003048121A1 Therapeutic benzamide derivatives
06/12/2003WO2003048112A1 Aminoacetonitrile derivatives and their use for controlling parasites
06/12/2003WO2003048109A1 Novel glucagon antagonists
06/12/2003WO2003047575A1 Therapeutic benzamide derivatives
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109724 Manufacture of 3-methyl-tetrahydrofuran from alpha-methylene-gamma-butyrolactone in a two step process
06/12/2003US20030109718 Enantioselective transformation of alpha, beta-unsaturated aldehydes using chiral organic catalysts
06/12/2003US20030109705 Novel cyanoenamines useful as ligands for modulating gene expression in plants or animals
06/12/2003US20030109703 Antiinflammatory agents; autoimmune disease
06/12/2003US20030109578 Treating acute and chronical inflammatory processes in a patent in need thereof which comprises administering to such patent an amount effective therefor of a compound or salt thereof according to claim 1.
06/12/2003US20030109577 Pharmaceutical composition containing citalopram
06/12/2003US20030109571 Thromboxane ligands without blood clotting side effects
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109547 Amidinophenylpyruvic acid derivatives
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/12/2003US20030109527 Novel hydroxy diphenylurea sulfonamides, compositions and intermediates thereof. The hydroxy
06/12/2003US20030106786 Method for distillative separation of mixtures containing tetrahydrofuran,$g(g)-butyrolactone and/or 1,4-butanediol
06/12/2003CA2468040A1 Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives
06/12/2003CA2466570A1 Aminoacetonitrile derivatives and their use for controlling parasites
06/11/2003EP1318148A1 Method of preparing optically pure (R)- or (S)- tetrahydrofuranyl ketone
06/11/2003EP1317436A1 Gaseous acid catalysis
06/11/2003EP1317431A2 Polyarylcarboxamides useful as lipid lowering agents
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
06/11/2003EP1317413A1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
06/11/2003EP1066276B1 Process for the synthesis of hiv protease inhibitors
06/11/2003EP0996614B1 Acrylonitrile compounds, process for their production and pesticides containing them
06/11/2003EP0611301B1 Chelator compositions comprising oxime compounds
06/11/2003CN1423748A Solution and crystal structures of MMP-13 active sidte and uses thereof
06/11/2003CN1423649A Sulfonyl oxazole amines and their use as 5-HT6 receptor ligand
06/11/2003CN1423644A Method for the preparation of citalopram
06/11/2003CN1423643A Method for the preparation of 5-cyanophthalide
06/11/2003CN1423642A Oxy-and amino-substituted tetrahydrofurl derivatives with antitumour activity
06/11/2003CN1423637A Novel substituted tricyclic compounds
06/11/2003CN1423635A Nitrogenous compounds and antiviral drugs containing the same
06/10/2003US6576770 Preparation of substituted phthalic anhydrides and substituted phthalimides
06/10/2003US6576766 Signal transduction inhibitors, compositions containing them
06/10/2003US6576664 1-amido-2-hydroxy-substituted-indanes; suppressing production of tumor necrosis factor
06/10/2003US6576662 Compounds having anticancer activity : process for their preparation and pharmaceutical compositions containing them
06/10/2003US6576661 Active ingredient combination having insecticidal and acaricidal characteristics
06/10/2003US6576630 Compounds and compositions as protease inhibitors
06/10/2003US6576614 Administering methyl ketones or closed hemiketal derivatives of aspartic acid
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/10/2003CA2117340C Synthesis of homochiral 2-hydroxy acids
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/10/2003CA2054619C Aminocoumaran derivatives, their production and use
06/05/2003WO2003045957A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
06/05/2003WO2003045934A1 Process for producing 5-substituted 2(5h)-furanone
06/05/2003WO2003045933A2 Preparation and use of gamma-butyrolactones as cross-linking agents
06/05/2003WO2003045898A1 Prodrugs of excitatory amino acids
06/05/2003WO2003045878A2 2,w-diaminocarboxylic acid compounds
06/05/2003WO2003045400A1 Combination of an il-1/18 inhibitor with a tnf inhibitor for the treatment of inflammation
06/05/2003WO2003045393A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
06/05/2003WO2003045368A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003US20030105343 Benzofuran compounds
06/05/2003US20030105341 Process for producing optically active gamma-butyrolactone
06/05/2003US20030105336 Pyrazole derivatives, their preparation and their use in pharmaceuticals
1 ... 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 ... 472